A Non-Interventional Study in Patients With Moderate to Severe Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)

Update Il y a 4 ans
Reference: NCT01663506

Woman and Man

  • | Country :
  • Estonia
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This non-interventional study will evaluate the use and efficacy of RoActemra/Actemra (tocilizumab) in patients with moderate to severe rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment according to the local label will be followed for 12 months.


Inclusion criteria

  • Rheumatoid Arthritis

Links